Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

Northwell Health reports pediatricians emphasize vaccines' effectiveness and safety, urging parents to follow the recommended ...

Sanofi sees continued growth and strong financials despite a pipeline setback. Click for this updated look at SNY stock ...

Federal officials say the FDA is reviewing reports of possible deaths in adults and children following COVID-19 vaccination.

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

The preventive therapies would be the latest called into question under U.S. Health Secretary Robert F. Kennedy Jr., a long-time promoter of anti-vaccine views.

Sanofi (SNY) and AstraZeneca (AZN) stocks are in focus as FDA to review their infant RSV treatments following safety concerns ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...